Skip to main content

Reducing Tobacco-Related Cancer Incidence and Mortality: A Workshop

Completed

The National Cancer Policy Forum convened a public workshop that included presentations and panel discussions exploring strategies to reduce tobacco-related cancer incidence and mortality. Tobacco use is responsible for more than 440,000 deaths each year and is the leading cause of preventable deaths in the United States. Around 30 percent of tobacco-related deaths in the United States are due to cancer. Tobacco use increases the incidence of many types of cancer and also can affect treatment outcomes. New efforts are needed to reduce smoking initiation and encourage cessation, including among individuals who have been diagnosed with cancer.

Description

An ad hoc committee will plan and conduct a public workshop, whose agenda will examine the impact of tobacco use on cancer incidence and mortality, and explore ways to reduce that impact. The workshop, which will feature invited presentations and discussion, will address such topics as:
· evidence linking tobacco use to the incidence, progression, and treatment outcome for various types of cancer;
· biological mechanisms responsible for that linkage and how to target them;
· the impact of State, Federal, and employer programs to reduce tobacco use;
· the new role of the FDA in regulating tobacco products; and
· international perspectives.
Workshop participants will discuss potential ways in which research could advance the prevention and treatment of tobacco-related cancers as well as enhance the regulation of tobacco products from a cancer perspective. Workshop participants will also explore potential ways to more broadly implement effective strategies to reduce tobacco use. An individually-authored summary of the workshop will subsequently be prepared by a designated rapporteur.

Collaborators

Sponsors

American Association for Cancer Research

American Cancer Society

American Society of Clinical Oncology

Association of American Cancer Institutes

Bristol Myers Squibb

C-Change

Centers for Disease Control and Prevention (CDC)

CEO Roundtable on Cancer

GlaxoSmithKline

National Cancer Institute

Novartis Oncology

Oncology Nursing Society

Sanofi

Staff

Sharyl Nass

Lead

SNass@nas.edu

Erin Balogh

Lead

EBalogh@nas.edu

Patrick Burke

PBurke@nas.edu

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.